Rectal Cancer Clinical Trial
Official title:
Radiographic Validation of the Inferior Mesenteric Artery Tie Level in Rectal Cancer Surgery
The inferior mesenteric artery is the feeding vessel for tumours in the rectum. When
performing surgery for these tumours, the surgeon can cut the vessel close to the aorta or
after the vessel bifurcates to the superior rectal artery and the left colic artery. A close
division is termed a high tie (and the other, a low tie) and might entail a better lymph node
extraction, possibly removing metastasis, but can also lead to nerve damage and e.g. bowel
dysfunction.
There is no clear evidence favouring either tie level, and large amounts of data are needed
to establish superiority as any effects is likely to be small. One such method is to use
national registries with prospectively collected data on e.g. level of tie and cancer
relapse. However, it is not always easy to determine the level of tie while in the operating
room and registries might also contain erroneous data.
In order to determine the validity of such data, comparisons to objective measures are
needed. This study is an attempt to correlate radiographic imaging to the suggested tie
level, as indicated by the surgeon in the operative report and by the nationwide Swedish
Colorectal Cancer Registry. If the registry variable tie level has a high correlation with
imagining, researchers can more reliably use the registry to establish the benefits and
drawbacks with high tie in rectal cancer surgery.
The level of tie of the inferior mesenteric artery in rectal cancer surgery has been a
controversy for decades. Proponents argue that lymph node harvest and bowel length can be
improved, while detractors state that nerve damage is likely and that blood perfusion to an
anastomosis is compromised. Few randomized clinical trials are available and these are
underpowered for long-term outcomes, mainly stating no difference. Observational studies
usually indicate no differences either, while lymph node harvest might be increased (though
not concerning node metastasis). Long-term outcomes such as survival and recurrence have not
been investigated with proper sample sizes to detect small effects. In effect, large scale
trials are unlikely to be conducted, and only population-based studies are likely to
accumulate adequate statistical power. One way would be to use nationwide registry data, such
as the Swedish Colorectal Cancer Registry, in which tie level as well as recurrence and
survival data are recorded. However, it is not always easy to determine the level of tie
while in the operating room and registries might also contain erroneous data. In order to
determine the validity of such data, comparisons to objective measures are needed. This study
is an attempt to correlate radiographic imaging to the suggested tie level, as indicated by
the surgeon in the operative report and by the nationwide Swedish Colorectal Cancer Registry.
If the registry variable tie level has a high correlation with imagining, researchers can
more reliably use the registry to establish the benefits and drawbacks with high tie in
rectal cancer surgery.
The RAVAL study plans to include 100 patients from the University Hospitals in Umeå and
Örebro, Sweden. Patients have been operated for rectal cancer and are contacted by telephone
or at the postoperative visit, before their planned 1-year radiological follow-up. All
patients sign informed consent for additional imaging with arterial phase contrast-enhanced
computerized tomography (CT), performed at the same time as their planned follow-up (for
detection of metastasis).
A dedicated study radiologist interprets the images, in conjunction with the routine
preoperative imaging, and determines the tie level that was performed at the rectal cancer
operation. Additional parameters such as vessel anatomy and the length of the artery stump
are recorded. Clinical data from operative reports and histopathology will also be noted.
When the study inclusion is completed, radiological determination of tie level will be
compared with the surgeon's impression of tie level as well as the tie level in the Swedish
Colorectal Cancer Registry.
The primary objective is to validate the level of tie in the registry, using sensitivity,
specificity and Cohen's kappa. The secondary objectives include validation of tie level in
comparison to operative reports, as well as artery stump length in relation to lymph node
harvest, use of laparoscopy, and cancer recurrence (using appropriate techniques such as
linear and Cox regression). The sample size is calculated per the primary objective, and
assumes 90% sensitivity and specificity, which requires 86 and 58 patients, respectively,
with a 10% margin of error. Attrition is expected, why 100 patients is determined to be
adequate.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06380101 -
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
|
N/A | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Recruiting |
NCT04323722 -
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Active, not recruiting |
NCT01347697 -
Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
|
N/A | |
Recruiting |
NCT04495088 -
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
|
Phase 3 | |
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03520088 -
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
|
N/A | |
Recruiting |
NCT05556473 -
F-Tryptophan PET/CT in Human Cancers
|
Phase 1 | |
Recruiting |
NCT04749381 -
The Role of TCM on ERAS of Rectal Cancer Patients
|
Phase 2 | |
Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
Recruiting |
NCT03283540 -
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
|
||
Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
Recruiting |
NCT05914766 -
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
|
N/A | |
Recruiting |
NCT04852653 -
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
|
||
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Terminated |
NCT02933944 -
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
|
Phase 1 | |
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A |